The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).
Critical limb ischemia, first defined in 1982, was intended to delineate a subgroup of patients with a threatened lower extremity primarily because of chronic ischemia. It was the intent of the original authors that patients with diabetes be excluded or analyzed separately. The Fontaine and Rutherford Systems have been used to classify risk of amputation and likelihood of benefit from revascularization by subcategorizing patients into two groups: ischemic rest pain and tissue loss. Due to demographic shifts over the last 40 years, especially a dramatic rise in the incidence of diabetes mellitus and rapidly expanding techniques of revascularization, it has become increasingly difficult to perform meaningful outcomes analysis for patients with threatened limbs using these existing classification systems. Particularly in patients with diabetes, limb threat is part of a broad disease spectrum. Perfusion is only one determinant of outcome; wound extent and the presence and severity of infection also greatly impact the threat to a limb. Therefore, the Society for Vascular Surgery Lower Extremity Guidelines Committee undertook the task of creating a new classification of the threatened lower extremity that reflects these important con...Continue Reading
Associated Clinical Trials
Peripheral arterial disease and subsequent cardiovascular mortality. A strong and consistent association
A prospective evaluation of transcutaneous oxygen measurements in the management of diabetic foot problems
Prediction of the immediate outcome of femoropopliteal saphenous vein bypass by angiographic runoff score
Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation
Lower extremity arterial reconstruction in the very elderly: successful outcome preserves not only the limb but also residential status and ambulatory function
Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial
Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies
Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia
Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia
Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization
Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions
High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study
Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia
Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification
A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE)
Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study.
Validation of the Finnvasc score in infrainguinal percutaneous transluminal angioplasty for critical lower limb ischemia
Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia
Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.
Clinical success using patient-oriented outcome measures after lower extremity bypass and endovascular intervention for ischemic tissue loss
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia
Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design.
Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not.
A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease
Gait and balance assessments as early indicators of frailty in patients with known peripheral artery disease
An analysis of IN.PACT DEEP randomized trial on the limitations of the societal guidelines-recommended hemodynamic parameters to diagnose critical limb ischemia
An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.)
IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes
Lower limb ischaemia in patients with diabetic foot ulcers and gangrene: recognition, anatomic patterns and revascularization strategies
Favorable outcomes of very elderly patients with critical limb ischemia who undergo distal bypass surgery
The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine
Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss
Predicting outcomes for infrapopliteal limb-threatening ischemia using the Society for Vascular Surgery Vascular Quality Initiative
Diabetic Foot Infection: Preliminary Results of a Fast-Track Program with Early Endovascular Revascularization and Local Surgical Treatment
Vascular surgery institutional-based quality and performance measures for the care of patients with critical limb ischemia
Clinical effect of wound depth in critical limb ischemia with tissue loss after endovascular treatment
Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia
Effect of oral nutritional supplementation on wound healing in diabetic foot ulcers: a prospective randomized controlled trial
Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction.
An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee
Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program
Peripheral Artery Disease Therapies May Perform Differently in Practice Than in Randomized Trials: The Need for Learning Health Systems
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)
New reporting standards are required to assess the impact of vascular intervention on patients with diabetic foot ulceration
The First-in-Man "Si Se Puede" Study for the use of micro-oxygen sensors (MOXYs) to determine dynamic relative oxygen indices in the feet of patients with limb-threatening ischemia during endovascular therapy
Prognosis of critical limb ischemia patients with tissue loss after achievement of complete wound healing by endovascular therapy
The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registry
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010
Update and validation of the Society for Vascular Surgery wound, ischemia, and foot infection threatened limb classification system
Outcomes and Influence of the Pedal Arch in Below-the-Knee Angioplasty in Patients with End-Stage Renal Disease and Critical Limb Ischemia
Carotid Artery Diseases
Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.
In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.
Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.